WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
PR & Media
Strategic support to drive communications programmes and build visibility
Marketing
Effectively promote products and services to generate leads
Design & Branding
Elevate company image with bespoke design services for websites and corporate materials
Investor Relations
Strengthen relationships with investors through targeted outreach

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
BioNow Empowering Women in Biotech
-
BIO-Europe 2026
-
ELRIG Protein Sciences in Drug Discovery 2026
-
Association of Molecular Pathology – Annual Meeting – 2026
Amphista Therapeutics to present AMX-883 data at American Society of Hematology (ASH) Annual Meeting
AMX-883-mediated BRD9 degradation disrupts hematopoietic transcriptional programs, promotes myeloid differentiation, and depletes leukemic stem cells in acute myeloid leukemia (AML) Additional abstract on AMX-883 BRAMLIE trial assessing safety, pharmacokinetics, and [...]
Bio-Rad Expands Precision Oncology Research Portfolio for Advanced Molecular Analysis Workflows
Expanded Portfolio Includes New Droplet Digital™ PCR Assays, Reagents and Technologies to Support Oncology Research Applications and Extend the Capabilities of the QX700™ ddPCR™ Systems HERCULES, Calif.—November 03, 2026—Bio-Rad Laboratories, [...]
Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials
Peer-reviewed Viewpoint ‘Fibrosis extent on HRCT: the principal structural imaging biomarker for antifibrotic trials’ presents argument for measuring both lung function and fibrosis extent in antifibrotic trials Evaluation of evidence [...]
























